With more than a decade of experience in funded projects, Radio6ense has built a robust network of collaborators, partners, and clients, solidifying its role as a leader in RAIN RFID and sensing technologies.
WISE PACK is funded under the Cyber 4.0 Competence Center call, promoted by the Italian Ministero delle Imprese e del Made in Italy (MIMIT). The project aims to enhance the cybersecurity and quality assurance of pharmaceutical products by introducing a novel solution based on wireless, battery-less sensors integrated directly into drug packaging. The system enables continuous monitoring of the micro-environment surrounding each pharmaceutical product throughout the production, storage, and distribution chain. By leveraging UHF RFID technology and edge/cloud software infrastructure, the project supports real-time detection of cyber-physical anomalies and potential counterfeiting attempts, turning each packaged drug into a distributed sensor that safeguards the integrity of the industrial plant.
SPIROHUB project aims to develop an innovative medical device, designed to monitor patients’ vital signs using low-power, non-invasive, and wireless sensors capable of long-term operation. The system enables real-time visualization and management of collected data, and leverages advanced Artificial Intelligence algorithms for the analysis and interpretation of physiological trends, supporting rapid and accurate diagnosis. SPIROHUB addresses challenges in monitoring vital signs in uncooperative patients over extended periods, such as during sleep studies, in comatose or neonatal patients, or in sports medicine applications. The system is made of five components primarily focusing on (1) heart rate, (2) blood oxygen saturation, (3) spirometry, (4) respiratory flow and oxygen, and (5) snoring, respiratory pressure, and respiratory pattern. The HUB (1) receives, processes, and displays signals received from the embedded ECG and the other wireless sensors. The main area of clinical interest is the polysomnography application. A pre-clinical validation phase is planned at the Sleep Center of Policlinico Tor Vergata.
SmartCPAP project aims to develop a prototype of an innovative respiratory support device (SmartCPAP) capable of self-regulating its operation in real time based on the user’s actual respiratory deficit. The system involves an advanced CPAP (Continuous Positive Airway Pressure) device that dynamically modulates the level of positive airway pressure. It will integrate sensors for Maximum Inspiratory and Expiratory Pressure (MIP/MEP) measurements and a wireless RFID nasal device to continuously collect breathing parameters. The real-time data will be processed by feedback algorithms supported by Artificial Intelligence (AI), enabling the device to provide adaptive and personalized respiratory assistance. The ultimate goal is to create a new generation of smart CPAPs that can dynamically adjust to the patient’s clinical needs.
RANGE-5G project aims to develop a swarm of advanced 5G-compatible drones and/or rovers that act as aerial relays to improve network access in areas with limited infrastructure, especially during natural disasters or emergencies. These autonomous vehicles form a mesh network to extend 5G coverage to remote or damaged areas, ensuring reliable, secure communication. By integrating intelligent network technologies and potentially using Reconfigurable Intelligent Surfaces (RIS), they support autonomous systems, infrastructure monitoring, and adapt to dynamic environments. These drones can also scan and sense the environment via RFID wireless sensors and on-board cameras.
PRECISION project aims to enhance the management of chronic airway diseases, specifically chronic rhinosinusitis and asthma, by introducing innovative remote respiratory monitoring and assessment tools. Within the project, RADIO6ENSE explores the use of RFID technology and mobile device connectivity for comprehensive monitoring of respiration, easing objective assessments provided by doctors, comfortable for the user. RADIO6ENSE’s RFID-based tool for automatic multi-parametric assessment of respiration – RESPIRA Kit – is tested and validated as a non-invasive monitoring of upper and lower airway conditions associated with chronic rhinosinusitis and asthma. Clinical trials are coordinated by Azienda Ospedaliera Universitaria di Sassari (Italy).
The FAIRS project supports Radio6ense’s 2025 internationalization strategy through participation in three major international fairs: RFID Journal Live! in Las Vegas (USA), RAIN in Action in Amsterdam (Netherlands), and Wireless IoT Tomorrow in Wiesbaden (Germany). These events have been strategically selected to strengthen Radio6ense’s presence in global markets by expanding its portfolio of international clients and laying the groundwork for the market launch of new Radio6ense-branded products. Radio6ense will showcase its cutting-edge technologies, finalized and in-development products, functional demonstrators, and mockups of industrial applications.
The FIERE project aims to support Radio6ense’s internationalization strategy by participating in two major international fairs in 2024: Wireless IoT Tomorrow in Germany and RFID-TA in the United States. The project’s primary objectives are to expand the company’s portfolio of international clients, establish a foundation for launching Radio6ense-branded products, and transition towards a hybrid business model combining services and products. These events will showcase Radio6ense’s innovative technologies, including the Tag Testing System (TTS), new products under development, and functional demonstrators of industrial applications.
Radio6ense has received funding under the Brevetti+ program to enhance the value of its patent “Sensore wireless epidermico, in particolare per la misura della temperatura corporea” (Patent No. 102020000001492).
With this support, the sensor was validated through experimental tests, optimized for large-scale production, and integrated with a secure data processing platform. Strategic partnerships were also established for clinical validation and commercialization, positioning it as a cutting-edge solution for digital health.
CLP: BRE0001502 CUP: C89J23000570008
Via della Tenuta di Torrenova 142, 00133, Roma
C.F./P.IVA 12270181006